Navigation Links
Next Safety Releases Advanced Respirator for Infectious Diseases
Date:8/5/2009

JEFFERSON, N.C., Aug. 5 /PRNewswire/ -- Next Safety, Inc. (NSI) announces advanced respirators that give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to the public respirator products the company developed for the bird flu influenza A subtype H5N1.

The respirators were originally developed for the bird flu (H5N1), which never became contagious. The Next Safety respirators are now being sold to the public for the first time. These respirators are a cross functional platform that supply highly purified air to half facemasks and air supply hoods.

Next Safety designed its respirators with input from the CDC and the World Health Organization along from the US army's famed AMRIID bioterrorism warfare center.

Next Safety's core competence is the development, design and rapid production of pulmonary products like its 9000 series respirators. Next Safety respirators are rated for 30,000 hours of continuous operation.

Next Safety respirator products are fabricated from battlefield-grade medical plastics. Next Safety uses compound filters that do not fail. Texas Instruments and EBM-Pabst power Next Safety's respirator products.

As with all respirator products, to be effective, Next Safety respirators must be used with proper eye protection and with a well-defined and understood decontamination program.

Next Safety is a leader in the development of pulmonary health products. It has a product line of advanced respirators that were developed for many different applications.

The company also develops pulmonary drug delivery products. It is a leader in the development of nicotine delivery devices for smoking cessation and nicotine replacement products.

Next Safety has 28 US patents that are either issued are pending for its products.

<
'/>"/>

SOURCE Next Safety, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
2. Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test
3. Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
4. MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus
5. EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements
6. AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
7. iCardiac Selected for Multiple Cardiac Safety Studies
8. Assessment of safety and efficacy of human embryonic stem cell therapy
9. Neurim Pharmaceuticals Reports Long Term Efficacy and Safety for Circadin(R) for Insomnia in Elderly Patients
10. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
11. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ember24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,N...company,today,announcedthatithassubmittedaMAAtothe...mpany,senzymereplacementtherapyindevelopment,forth...eting,applicationforvelaglucerasealfathathasbeensu...ndCanada. , Basedonaglobalsupplyshortageofthe...
(Date:11/24/2009)...y,November24/PRNewswire/--HealthRoboticstodayannou...roupofselected,investors.ThisrecentlyformedToronto...sCanada,Inc.andwillmarket,install,andsupport,Healt...the,revolutionaryproductofferingsi.v.STATION(TM),i...llalsoprovideassistanceonan"asneeded,basis"toitsst...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(...1stAnnualPiperJaffrayHealthCareConference.Theconfe...Hotel. ,, CTIwillpresentonTuesday,December1at11...bcastofCTI,spresentationwillbeavailableat www.cell...yafterwards. , ,PiperJaffrayHealthCareConference,...
(Date:11/23/2009)...g promises ultra-fast communication, computation a...tion. But trying to use quantum states as carriers... Now two physicists have shown, mathematically, ho...mmunication, while keeping the information intact....hysical Review Letters and highlighted with a Vie...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... that the anticoagulant Clexane(R) (enoxaparin sod...Japan by the Ministry of Health, Labour and,Welfar...E) in patients,undergoing orthopaedic surgery of t...l knee replacement and hip fracture surgery., Ven...complication among,patients hospitalized for ortho...
..., Inc. (Nasdaq: ONXX ) today announced that it wi...n Wednesday, January 30, at 8:30,a.m. Eastern Time...the,presentation at:, http://www.wsw.com/webcast...g on 15 minutes early in order to,register and dow...participate during the live webcast, a recorded re...
...-45 and 0641-2450-41;, LOTS: 107054, 117085, 047... 107111, DEERFIELD, Ill...unced the voluntary recall of nine lots of heparin...i-dose vials. The company,began recalling the lots...e,to an increase in the number of reports of adver...
Other Biology Technology:Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials 2
(Date:11/23/2009)...y the Wildlife Conservation Society says that west...e Republic of Congopart of the "mother lode" of mo...ecoming increasingly threatened by growing humans ...rotection of the swamp forests adjacent to the sou...cent surveys confirmed that high densities of the ...
(Date:11/23/2009)... Current research suggests that a common oral bact...ted report by Nichols et al, "Unique Lipids from a...LR2 Ligands Capable of Enhancing Autoimmunity," ap...Journal of Pathology . , Multiple sclerosis (MS)...ain and spinal cord, affects nearly 1 in 700 peopl...
(Date:11/23/2009)...The only swine vaccine available for the H1N1 viru... with the virus. The vaccination marks the first t...d with the pandemic flu., Iowa State University,...ped the vaccine this summer and has been shipping ...s and Illinois for several weeks., The latest va...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Highmark Inc Awards 247 500 to 15 Pennsylvania Nonprofit Organizations 56598 1Highmark Inc Awards 247 500 to 15 Pennsylvania Nonprofit Organizations 56598 2Highmark Inc Awards 247 500 to 15 Pennsylvania Nonprofit Organizations 56598 3Highmark Inc Awards 247 500 to 15 Pennsylvania Nonprofit Organizations 56598 4YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 1YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 2YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 3YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 4YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 56595 5PDL BioPharma to Present at BioCentury Newsmakers Conference on September 16 2009 56592 1
...Marine Life (CoML), a team of world renown scienti...reef biodiversity in the largest fully protected m... Islands Marine National Monument. Led by the Nat...) Pacific Islands Fisheries Science Center, with f... and the Alfred P. Sloan Foundation, this 23-day r...
... a cloudy or damaged cornea are seeing some remark...ial implant that takes the place of the cornea, th...dow on the world. , The results of operations invo...to receive the device, performed by physicians at ...lleague at Johns Hopkins University, are being ann...
... in their 60s have as many risk factors for heart ...ing to research led by demographers at the Univers...hed in the current issue of the Journal of Women,s...en older men were at greater risk for heart diseas...ars, older women are doing worse, while men are do...
Other Biology News:First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 3Artificial cornea offers better results for infants, some blind patients 2Artificial cornea offers better results for infants, some blind patients 3Artificial cornea offers better results for infants, some blind patients 4Artificial cornea offers better results for infants, some blind patients 5Artificial cornea offers better results for infants, some blind patients 6Sex and the heart: It's not what you think 2
...ble ESI Chip allow users to take full advantage of...rs for life science applications. Integrating the ...ysis for increased throughput for small molecule a...on times for proteomics and metabolism application...
...urce provides fast, easy, and ultrasensitive analy.... Paired with an Agilent 6300 Series Ion Trap LC/M...e PDF-MALDI source is ideal for fast analysis of 2...MS/MS spectra at attomole levels. The PDF-MALDI so...
...rotator/rocker with a multi-action platform. It p...rocking/shaking, rotating/rocking, rolling/rocking... all these actions. The precision-engineered movi...sts of a two-sided, stainless steel platform that ...
McCoy's 5A Medium, 500 mL from StemCell Technologies, Inc.
Biology Products: